Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase 4 3Phase 3 3Phase NA 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Smoking Cessation 3Tobacco Use Cessation 1Pain 1Neoplasms 1Agnosia 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Varenicline × Clear all
NCT02162849 2026-02-09

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

M.D. Anderson Cancer Center

Phase 4 Active not recruiting
204 enrolled

Smoking Cessation, Tobacco Use Cessation

NCT06218823 2025-10-27

Tobacco Treatment Comparison for Cancer Care

University of Wisconsin, Madison

Phase 4 Completed
52 enrolled 9 charts

Neoplasms, Smoking Cessation

NCT06029907 2025-09-04

Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.

Duke University

Phase 4 Completed
19 enrolled

Agnosia, Pain, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡